Tyligand Pharmaceuticals (Suzhou) Limited clinical trial pipeline
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-21
What changed in the last 30 days
1 trial changed in the last 30 days: 0 stopped, 1 with a notable change, 0 with minor changes only.
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates
Active trials by phase
| Phase 1/2 | 1 |
Disease areas by active trials
Colorectal Cancer (1) · Lung Cancer (1) · Non-Small Cell Lung Cancer (NSCLC) (1) · Pancreatic Cancer (1)
Get alerts when Tyligand Pharmaceuticals (Suzhou) Limited's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.